These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2416496)

  • 21. Interleukins in pulmonary sarcoidosis. Dissociative correlations of lung interleukins 1 and 2 with the intensity of alveolitis.
    Yamaguchi E; Okazaki N; Tsuneta Y; Abe S; Terai T; Kawakami Y
    Am Rev Respir Dis; 1988 Sep; 138(3):645-51. PubMed ID: 3264477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis.
    Baughman RP; Lower EE
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1268-71. PubMed ID: 2252243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bronchoalveolar immunoglobulins in sarcoidosis].
    Bauer W; Gorny MK; Morell A; Baumann HR
    Schweiz Med Wochenschr; 1985 Jan; 115(3):103-5. PubMed ID: 3871964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment.
    Chadelat K; Baculard A; Grimfeld A; Tournier G; Boule M; Boccon-Gibod L; Clement A
    Pediatr Pulmonol; 1993 Jul; 16(1):41-7. PubMed ID: 8414740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BAL lymphocyte activation antigens and diffusing capacity are related in mild to moderate pulmonary sarcoidosis.
    Xaubet A; Agustí C; Roca J; Picado C; Rodriguez-Roisin R
    Eur Respir J; 1993 May; 6(5):715-8. PubMed ID: 8519382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cells in bronchoalveolar lavage in sarcoidosis: correlation with alveolar lymphocytes.
    Rottoli P; Rottoli L; Perari MG; Collodoro A; Carriero G; Bianco S
    Respiration; 1988; 54 Suppl 1():42-8. PubMed ID: 3231905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunity of the lung--with special reference to sarcoidosis].
    Izumi T; Kitaichi M; Nagai S
    Kokyu To Junkan; 1983 Oct; 31(10):1046-56. PubMed ID: 6198702
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of the activity and control of the course of sarcoidosis using bronchoalveolar lavage].
    Bauer W; Simona R; Morell A; Baumann HR
    Schweiz Med Wochenschr; 1984 Jun; 114(25):920-4. PubMed ID: 6235580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis.
    Lawrence EC; Teague RB; Gottlieb MS; Jhingran SG; Lieberman J
    Am J Med; 1983 May; 74(5):747-56. PubMed ID: 6301276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis.
    Costabel U; Bross KJ; Guzman J; Nilles A; Rühle KH; Matthys H
    Ann N Y Acad Sci; 1986; 465():418-26. PubMed ID: 2942077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunologic characterization of lymphocytes using monoclonal antibodies and immunoglobulin determination in bronchoalveolar lavage in patients with sarcoidosis].
    Ballin A; Bigl H; Ferner S; Leonhardt P
    Prax Klin Pneumol; 1988 Jul; 42(7):544-6. PubMed ID: 3263638
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.
    Hunninghake GW; Crystal RG
    J Clin Invest; 1981 Jan; 67(1):86-92. PubMed ID: 6969734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Procollagen-III-peptide in bronchoalveolar lavage fluid as an index of fibrosis in sarcoidosis and idiopathic lung fibrosis?].
    Teschler H; Costabel U; Ziesche R; Freitag L; Matthys H; Konietzko N
    Pneumologie; 1990 Feb; 44 Suppl 1():217-8. PubMed ID: 2367369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenetic and clinical significance of the adhesion molecule expression on T cells of the lung in sarcoid alveolitis].
    Gerli R; Galandrini R; Agea E; Bini P; Tognellini R
    Medicina (Firenze); 1990; 10(1):38-9. PubMed ID: 2199744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [T-lymphocyte subpopulations in bronchoalveolar lavage in pulmonary sarcoidosis and other interstitial pulmonary diseases].
    Petrek M; Kolek V
    Cas Lek Cesk; 1993 Jun; 132(12):365-8. PubMed ID: 8343944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alveolitis in patients with sarcoidosis].
    Tomić I; Dangubić V; Popović L; Colić M; Plavec G
    Vojnosanit Pregl; 1992; 49(6):547-51. PubMed ID: 1297251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.
    Hunninghake GW; Gadek JE; Young RC; Kawanami O; Ferrans VJ; Crystal RG
    N Engl J Med; 1980 Mar; 302(11):594-8. PubMed ID: 6965420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets.
    Greening AP; Nunn P; Dobson N; Rudolf M; Rees AD
    Thorax; 1985 Apr; 40(4):278-83. PubMed ID: 3875160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-induced proliferative response of lavage and blood T lymphocytes. Comparison of cells from normal subjects and patients with sarcoidosis.
    Lecossier D; Valeyre D; Loiseau A; Cadranel J; Tazi A; Battesti JP; Hance AJ
    Am Rev Respir Dis; 1991 Oct; 144(4):861-8. PubMed ID: 1928963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.